HealthTech

Setpoint Therapeutics

Setpoint Therapeutics raises $185M Series B

$185M
Total Raised
Series B
Latest Round
2020
Founded
100+
Employees
San Francisco, CA
1 min read

Quick Facts

Latest Round Size
$185M
Latest Round Date
August 2025

Setpoint Therapeutics: Series B Funding Round

Setpoint Therapeutics has successfully raised $185M in Series B funding.

Company Overview

Biotech developing therapies for autoimmune diseases

Funding Details

The Series B round was led by Multiple investors.

Company Information

  • Headquarters: San Francisco, CA
  • Founded: 2020
  • Employees: 100+
  • Category: HealthTech

Investment

Setpoint Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Multiple investors: Verified investor in Series B

Key Investors

Multiple investors
Lead Investor
Verified investor in Series B

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources